JPRN-UMIN000016455已完成未知
A double-blind, randomized, placebo-controlled clinical trial to investigate the effect of the beverage containing plant extract (Ex.no.14154) - A clinical trial to investigate the effect of the beverage containing plant extract
ew drug research center, Inc.0 个研究点目标入组 150 人开始时间: 2016年3月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
There was a significant difference in primary outcome
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects with a history of allergy to medicine and food 2)Subjects who have serious historical disease or have marked impairment of heart, lung,liver, kidney, heart, or gastrointestinal tract functions (excluding extirpation of vermiform appendix). Subjects who have above one relevance to the following conditions 1.TG is above 400 mg/dL 2.total-cholesterol is above 300 mg/dL 3.Fast Blood Glucose is above 126 mg/dL and HbA1c(NGSP)is above 6.5 % 4.AST(GOT)is above 100 U/L 5.ALT(GPT)is above 100 U/L 6.gamma-GTP is above 200 U/L 7.Hemoglobin is below 11.9 g/dL(male), 10.9 g/dL(female) 8.Creatinine is below 1.30 mg/dL(male), 1.00 mg/dL(female) 9.Subjects who don't empty the bowels more than 3 days, or who feel a sense of incomplete evacuation even if who empty the bowels every day 3)Subjects who donated 400 mL of blood within 12 weeks before starting of administration, or who donated 200 mL of blood within 4 weeks or donated blood component within 2 weeks 4)Subjects with systolic blood pressure under 90 mmHg 5)Subjects who smoke excessively and drink alcohol habitually 6)Subjects whose eating habits are extremely irregular or who are midnight and irregular shift workers 7)Subjects who regularly use medicine (depressor drugs, hypolipidemic agents, hypoglycemic drugs, polyene phosphatidylcholine, linoleic acid derivatives, clofibrate, nicomol, unsaponified soybean oil, elastase, artoron, probucol, cholestyramine, HMG-CoA reductase inhibitor, anorexiant drug, etc.), Food for Specified Health Uses, special health-promoting foods known to alter this trial. 8)Subjects who plan to become pregnant, who are during pregnancy, or who are nursing 9)Subjects who participate in other clinical trials or whose participation finishes within 4 weeks prior to the current clinical trial 10)Subjects who are ineligible due to physician's judgment
研究者
相似试验
已完成
不适用
A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the beverage containing plant extractsJPRN-UMIN000023491Fukuhara Clinic150
进行中（未招募）
1 期
A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumoniaCoronavirus infectionMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-001686-36-FRASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE168
尚未招募
2 期
A Clinical Trial to study the efficacy & safety of Colebrookea Oppositifolia (Aceteoside) in acute hepatitis patients.CTRI/2008/091/000090Council of Scientific & Industrial Research200
进行中（未招募）
不适用
A double-blind, placebo-controlled efficacy (as assessed by post-bronchodilator FEV1) and safety study of 5 mg RO3300074 once-daily for 2 years in subjects with smoking-related, moderate-to-severe COPD with emphysema receiving concurrent optimal COPD drug therapy.EUCTR2006-002525-23-ISF. Hoffmann-La Roche Ltd480
进行中（未招募）
1 期
A double-blind, placebo-controlled efficacy (as assessed by post-bronchodilator FEV1) and safety study of 5 mg RO3300074 once-daily for 2 years in subjects with smoking-related, moderate-to-severe COPD with emphysema receiving concurrent optimal COPD drug therapy.EUCTR2006-002525-23-GBF. Hoffmann-La Roche Ltd480